ArticleChemistry & biodiversity2026
Biomass Derived Carbon Quantum Dots for the Green Synthesis of Aryl Semicarbazones and Their In Silico Evaluation.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, a green and efficient method has been developed for the preparation of aryl semicarbazones using Kigelia pinnata flower-derived carbon quantum dots (KP-CQDs) as a sustainable catalyst. The reaction between various aldehydes/acetophenones and semicarbazide (SC) hydrochloride was carried out smoothly at room temperature in an ethanol-water (1:4) solvent system, and excellent yields (83%-95%) were achieved within a short reaction time of 5-20 min, demonstrating the high catalytic efficiency of KP-CQDs. A total of nine derivatives were synthesized, among which six compounds are reported for the first time. Furthermore, the biological potential of these compounds was investigated through in silico studies. The molecules were subjected to prediction of activity spectra for substances (PASS) online prediction to predict probable biological targets, and based on these predictions, molecular docking was performed against human mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme A synthase 2 (Protein Data Bank [PDB] ID: 2WYA), hepatitis A virus 3C protease (PDB ID: 1HAV), and foot-and-mouth disease virus (FMDV) 3C protease (PDB ID: 2WV4). On conducting molecular docking, molecules 3f (-15.57 kcal/mol), 3c (-5.61 kcal/mol), and 3e (-9.44 kcal/mol) showed remarkable activity with 2WYA, 1HAV, and 2WV4, respectively. This method offers several key advantages, including the use of a green and reusable CQD catalyst, mild reaction conditions, short reaction times, excellent yields, and the preparation of new semicarbazone derivatives with unexplored biological activities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.